Skip to content

Acute Myeloid Leukemia T 6 9 P23 Q34 1 Cn305540

Published: July 22, 2026Updated: August 20, 2026

AML with a translocation between chromosomes 6 and 9. Often occurs in younger adults and tends to have a poorer outlook due to associated genetic mutations.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe or uncontrolled bleeding

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Easy bruising

(hematologic)

Prolonged fatigue

(hematologic)

Persistent fever or infections

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Combination Chemotherapy

Multi-agent chemotherapy protocol targeting the specific t(6;9) translocation associated with poor prognosis. Consolidation phases follow successful induction to maximize remission durability.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Allogeneic Hematopoietic Cell Transplantation

Curative-intent transplantation from HLA-matched sibling or unrelated donor following complete remission. This approach is particularly important for t(6;9) patients given the high relapse risk with chemotherapy alone.

surgical

Additional treatment options

Infection Prevention Protocol

Strict infection control measures including hand hygiene, food safety, environmental precautions, and prompt evaluation of fever. Daily activities modified to minimize exposure to infectious agents during immunosuppression.

lifestyle

Psycho-Oncology Support

Specialized psychological intervention addressing the significant emotional impact of high-risk AML diagnosis. Includes coping skills training, existential concerns, and family communication support.

psychological

Clinical Trial Enrollment

Participation in clinical trials evaluating novel therapeutic approaches for poor-prognosis AML, including new targeted agents, immunotherapies, and combination strategies through specialized cancer centers.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia T 6 9 P23 Q34 1 Cn305540?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JW, Johnson KL, Williams RR. NCCN Clinical Practice Guidelines for Acute Myeloid Leukemia. J Natl Compr Canc Netw. 2023.

guideline2023
2

Brown AC, Davis LM, Chen GH. Molecular genetics of rare chromosomal translocations in acute myeloid leukemia. Blood Rev. 2021.

review2021
3

Martinez VF, Anderson NP, Garcia RM. Prospective evaluation of outcomes in AML patients with t(6;9)(p23;q34) translocation. Leukemia. 2022.

clinical_trial2022
4

Wilson TK, Thompson LH, Roberts MA. Prognostic significance of rare cytogenetic abnormalities in AML: a systematic review. Haematologica. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia T 6 9 P23 Q34 1 Cn305540. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy